What is the recommended N‑acetylcysteine dosing regimen for acetaminophen (paracetamol) overdose in adults and children?

N-Acetylcysteine Dosing for Paracetamol Poisoning

Administer N-acetylcysteine (NAC) immediately using a two-bag intravenous regimen: 200 mg/kg over 4 hours, followed by 100 mg/kg over 16 hours, starting treatment ideally within 8-10 hours of ingestion for patients at risk based on the Rumack-Matthew nomogram. 1

Risk Stratification and Treatment Initiation

The Rumack-Matthew nomogram is the cornerstone for determining who needs NAC treatment in acute single-time-point ingestions 2. Do not wait for acetaminophen levels to return before starting NAC if the history suggests a potentially toxic ingestion within 24 hours 3.

Key Decision Points:

• Patients above the nomogram line (possible or probable risk): Start NAC immediately to reduce severe hepatotoxicity and mortality 2
• Patients below the nomogram line (no risk): Do not administer NAC 2
• Unknown time of ingestion or unreliable history: Start NAC empirically and assess based on acetaminophen levels and liver function tests 2

Recommended Dosing Regimens

First-Line: Two-Bag IV Regimen (Preferred)

The two-bag regimen has replaced older protocols due to significantly reduced adverse reactions while maintaining equivalent efficacy 1:

• Loading dose: 200 mg/kg IV over 4 hours
• Maintenance dose: 100 mg/kg IV over 16 hours
• Total duration: 20 hours
• Total dose: 300 mg/kg

This simplified regimen reduces non-IgE-mediated reactions (flushing, urticaria) that commonly occurred with the older three-bag protocol's rapid loading dose 1.

Alternative: Three-Bag FDA-Approved Regimen

The traditional FDA-labeled regimen remains acceptable 3:

• Loading dose: 150 mg/kg IV over 1 hour (or 15 minutes in some protocols)
• Second dose: 50 mg/kg IV over 4 hours
• Third dose: 100 mg/kg IV over 16 hours
• Total duration: 21 hours
• Total dose: 300 mg/kg

However, this regimen has higher rates of adverse reactions (14-20%) due to the rapid initial infusion 4, 5.

Oral NAC (When IV Not Available)

For settings where IV NAC is unavailable 3:

• Loading dose: 140 mg/kg orally
• Maintenance: 70 mg/kg orally every 4 hours for 17 doses
• Total duration: 72 hours
• Dilute 20% solution to 5% with diet cola or soft drinks
• If vomiting occurs within 1 hour, repeat that dose

Timing is Critical

The efficacy of NAC is time-dependent, with outcomes dramatically worsening after 10 hours post-ingestion 2:

• <8 hours: Virtually no hepatotoxicity (0-2.9%) 2
• 8-10 hours: Minimal hepatotoxicity (6.1%) 2
• 10-16 hours: Hepatotoxicity increases to 29% 2
• 16-24 hours: Hepatotoxicity reaches 62% 2
• >24 hours: Still beneficial but with increased morbidity 2

Special Circumstances Requiring Modified Dosing

Massive Overdoses (>30g or >500 mg/kg)

For paracetamol concentrations more than double the nomogram line, increase NAC dosing 1:

• Use higher doses of acetylcysteine (specific protocols vary, but consider doubling the maintenance infusion rate)
• Extended treatment beyond 20 hours may be necessary
• Monitor closely for hepatotoxicity development

Recent evidence suggests standard NAC dosing may be insufficient for massive overdoses, though the optimal high-dose regimen remains under investigation 6, 7.

Modified-Release Paracetamol

All potentially toxic modified-release ingestions (≥10g or ≥200 mg/kg, whichever is less) should receive a full NAC course 1:

• Standard nomogram may not apply due to delayed absorption
• For ingestions ≥30g or ≥500 mg/kg: use increased NAC doses
• Obtain serial acetaminophen levels (4-hour intervals) to assess ongoing absorption

Repeated Supratherapeutic Ingestions

Patients with hepatotoxicity from repeated supratherapeutic ingestions should receive NAC 2:

• The nomogram does not apply to these cases
• Base treatment on presence of detectable acetaminophen plus elevated transaminases
• Continue NAC until acetaminophen is undetectable and liver function stabilizes

Established Hepatotoxicity or Fulminant Hepatic Failure

Administer NAC to patients with hepatic failure or hepatotoxicity thought to be due to acetaminophen, regardless of time since ingestion 2:

• NAC has benefit even in established liver injury
• Continue treatment until clinical improvement or transplant evaluation
• Consider extending beyond standard 20-hour protocol

Early Stopping Criteria

NAC can be discontinued early (before completing the full regimen) when all of the following are met 8, 1:

• Acetaminophen level <10 mg/L (or undetectable)
• ALT/AST stable or falling and within normal limits
• INR <1.3 (or normal for the patient)
• Patient is asymptomatic

This approach (SNAP protocol, NACSTOP pathway) reduces unnecessary treatment duration and hospital stay in low-risk patients 8.

Extension Criteria

Continue NAC beyond the standard 20-hour protocol if 8, 1:

• Acetaminophen remains detectable (≥10 mg/L)
• Transaminases are rising or remain elevated
• INR is elevated
• Patient has ongoing symptoms

Continue the maintenance infusion rate (100 mg/kg over 16 hours, or 6.25 mg/kg/hour) until criteria for stopping are met.

Practical Considerations

Dosing Weight

• Maximum weight cap: Many institutions cap dosing at 100 kg to reduce adverse reactions, though this practice varies 9
• For obese patients, consider actual body weight up to 110 kg, then use 110 kg as maximum

Adverse Reactions

Anaphylactoid reactions occur in 10-20% of patients, typically during the loading dose 4, 5:

• Manifestations: flushing, urticaria, pruritus, rarely bronchospasm or hypotension
• Management: Temporarily stop infusion, give antihistamines, then restart at slower rate
• These are not true IgE-mediated allergies; NAC should not be permanently discontinued

Common Pitfalls to Avoid

1. Waiting for acetaminophen levels before starting treatment: If history suggests toxic ingestion within 24 hours, start NAC immediately 3

2. Drawing levels too early: Acetaminophen levels drawn <4 hours post-ingestion cannot be plotted on the nomogram reliably 2

3. Applying the nomogram to inappropriate cases: The nomogram only applies to single acute ingestions with known time, not to repeated supratherapeutic ingestions or modified-release formulations 1

4. Stopping NAC prematurely in high-risk patients: Always check stopping criteria before discontinuing treatment 8

5. Using activated charcoal after NAC has started: Activated charcoal adsorbs NAC and reduces effectiveness; if charcoal is indicated, give it before NAC or perform gastric lavage first 3

Pediatric Considerations

The same weight-based dosing applies to children >12 years 2. For children ≤12 years, the guidelines provided here do not directly apply, though NAC remains the antidote of choice with similar weight-based dosing principles.

Resource-Limited Settings

In settings where acetaminophen levels are delayed or unavailable 8:

• Use dose and timing history to guide empiric NAC treatment
• Start NAC for any potentially toxic ingestion (>150 mg/kg or >7.5g in adults)
• Oral NAC is acceptable when IV formulation is unavailable 3